Ultragenyx Pharmaceutical Market Sentiment

Ultragenyx Pharmaceutical Inc

RARENASDAQ

$15.95

0.030.19%

Últ. Act.: Oct 23, 7:15 AM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ultragenyx Pharmaceutical Market Sentiment - Benzinga

Ultragenyx Pharmaceutical Market Sentiment

Market sentiment signals for Ultragenyx Pharmaceutical (RARE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 21.4% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

28 analysts

Options Flow (P/C)

—

Avg Consensus PT

$47

+194.8%

Highest Price Target

$140

+781.6%

Piper Sandler

Lowest Price Target

$16

+0.8%

UBS

Short Interest

21.4%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 15, 2026	UBS	Joon Lee—	+0.8%	$16	Initiate	Neutral
Sep 21, 2026	Evercore ISI Group	Liisa Bayko—	+13.4%	$16 → $18	Maintained	In-Line
Sep 21, 2026	Barclays	Eliana Merle—	+120.4%	$32 → $35	Maintained	Overweight
Sep 18, 2026	Morgan Stanley	Maxwell Skor—	+25.9%	$18 → $20	Maintained	Equal-Weight
Sep 18, 2026	Citigroup	Yigal Nochomovitz—	+101.5%	$31 → $32	Maintained	Buy
Sep 18, 2026	Canaccord Genuity	Whitney Ijem—	+145.6%	$37 → $39	Maintained	Buy
Sep 18, 2026	Cantor Fitzgerald	Kristen Kluska—	+145.6%	$33 → $39	Maintained	Overweight
Sep 17, 2026	Citigroup	Yigal Nochomovitz—	+95.2%	$28 → $31	Maintained	Buy
Sep 4, 2026	Goldman Sachs	Salveen Richter—	+19.6%	$28 → $19	Maintained	Neutral
Sep 4, 2026	Barclays	Eliana Merle—	+101.5%	$43 → $32	Maintained	Overweight
Sep 3, 2026	JP Morgan	Anupam Rama—	+126.7%	$80 → $36	Downgrade	Overweight→Neutral
Sep 3, 2026	Jefferies	Maury Raycroft—	+76.3%	$77 → $28	Maintained	Buy
Sep 3, 2026	William Blair	Sami Corwin—	—	—	Downgrade	Outperform→Market Perform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+76.3%	$58 → $28	Maintained	Buy
Sep 3, 2026	TD Cowen	Yaron Werber—	+13.4%	$49 → $18	Maintained	Buy
Sep 3, 2026	Wells Fargo	Benjamin Burnett—	+13.4%	$50 → $18	Maintained	Overweight
Sep 3, 2026	Canaccord Genuity	Whitney Ijem—	+133.0%	$83 → $37	Maintained	Buy
Sep 3, 2026	Wedbush	Laura Chico—	+44.8%	$30 → $23	Maintained	Neutral
Sep 3, 2026	Evercore ISI Group	Liisa Bayko—	+0.8%	$34 → $16	Downgrade	Outperform→In-Line
Sep 3, 2026	Baird	Joel Beatty—	+0.8%	$40 → $16	Downgrade	Outperform→Neutral
Sep 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+57.4%	$50 → $25	Maintained	Buy
Sep 3, 2026	Cantor Fitzgerald	Kristen Kluska—	+107.8%	$103 → $33	Maintained	Overweight
Aug 28, 2026	Wells Fargo	Michael Turrin—	+214.9%	$46 → $50	Maintained	Overweight
Aug 25, 2026	JP Morgan	Anupam Rama—	+403.8%	$75 → $80	Maintained	Overweight
Aug 21, 2026	Morgan Stanley	Jeffrey Hung—	+366.0%	$67 → $74	Maintained	Overweight